Laboratory research materials for in vitro use only.

$20 flat-rate shipping across Canada  ·  Free shipping on orders over $350

Kisspeptin

For laboratory research use only (in vitro). Not for human or animal use.

15% OFF Create an account and get 15% off your first order
Select Size — Price Per Vial

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$70.99Your price
3-4 units5% off$67.44Your price
5-9 units10% off$63.89Your price
10+ units Best Value15% off$60.34Your price

25% Pre-Order Discount Applied

The 25% pre-order discount is the maximum available and overrides volume pricing. There is no additional volume discount.

Pay via Interac e-Transfer

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

Interac e-Transfer

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence Kisspeptin-10: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
Molecular Weight 5861.5 Da
Molecular Formula C257H383N69O74S3
CAS Number 374675-21-5
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Phase2

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Kisspeptin is a family of neuropeptides encoded by the KISS1 gene, with kisspeptin-10 (the C-terminal decapeptide) being the minimal active fragment with the molecular formula C257H383N69O74S3 and an approximate molecular weight of 5861.5 Da for the full-length kisspeptin-54 (CAS number 374675-21-5). Kisspeptin functions as a master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, playing critical roles in puberty onset, reproductive function, and fertility.

All kisspeptin isoforms (kisspeptin-54, -14, -13, and -10) share a conserved C-terminal RF-amide motif required for receptor activation. Kisspeptin was originally identified as Metastin for its metastasis-suppressing properties and is also referred to as KiSS-1 peptide.

Property Value
Molecular Formula C257H383N69O74S3
Molecular Weight ~5861.5 Da (kisspeptin-54)
CAS Number 374675-21-5
Sequence (Kisspeptin-10) Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
Research Status Phase 2 clinical trials

Research Overview

Kisspeptin has been investigated in Phase 2 clinical trials and extensive preclinical research in reproductive endocrinology. The primary mechanism involves binding to KISS1R (GPR54), a Gq/11-coupled GPCR expressed on GnRH neurons in the hypothalamus. Upon binding, kisspeptin activates phospholipase C-beta, generating IP3 and DAG, with the resulting intracellular calcium elevation depolarizing and activating GnRH neurons to trigger pulsatile GnRH release.

Kisspeptin is recognized as the most potent known endogenous stimulator of the reproductive hormone cascade, sitting at the apex of the HPG axis. Its discovery explained how metabolic status, circadian rhythms, and pubertal development are integrated with reproductive function.

Key areas of published research include:

  • Reproductive Endocrinology: Clinical studies have demonstrated that kisspeptin administration potently stimulates LH and FSH release through GnRH neuron activation, with applications in fertility research including triggering oocyte maturation as an alternative to hCG in assisted reproduction protocols.
  • Puberty and Development: Loss-of-function mutations in KISS1 or KISS1R cause hypogonadotropic hypogonadism and absent puberty in humans, establishing the kisspeptin system as essential for pubertal initiation and reproductive competence.
  • Metastasis Suppression: Kisspeptin was originally identified through its metastasis-suppressing activity, and ongoing research examines KISS1/KISS1R signaling in cancer biology and tumor dissemination.

Kisspeptin-based therapeutics are in Phase 2 clinical development for reproductive medicine applications.

Specifications

All Kisspeptin supplied by Prescott Bio Canada is manufactured to research-grade standards.

Specification Detail
Purity >98% (HPLC)
Form Lyophilized powder
Appearance White to off-white powder
Storage (lyophilized) -20°C, protected from light
Storage (reconstituted) 2-8°C, use within 30 days
Solubility Soluble in bacteriostatic water, sterile water, or normal saline

Each vial is accompanied by a Certificate of Analysis (COA) documenting purity, identity, and endotoxin testing.

Research Applications

Kisspeptin is supplied exclusively for in vitro and in vivo laboratory research. Published experimental applications include:

  • Reproductive endocrinology and HPG axis regulation research
  • GnRH neuron physiology and KISS1R signaling studies
  • Fertility and assisted reproduction protocol development
  • Puberty onset mechanisms and neuroendocrine development research
  • Cancer metastasis suppression and KISS1 biology studies
  • Metabolic-reproductive axis integration research

Researchers should consult the primary literature and institutional review protocols before designing experiments with Kisspeptin.

Storage and Handling

Lyophilized powder: Store at -20°C in the original sealed vial, protected from light and moisture. Under these conditions, Kisspeptin maintains stability for up to 24 months.

Reconstituted solution: Reconstitute with bacteriostatic water or sterile water to the desired concentration. Store reconstituted Kisspeptin at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

Handling precautions: This product is intended for research use only (RUO). Not for human or veterinary diagnostic or therapeutic use. Handle using standard laboratory safety practices including appropriate PPE.

Additional information

Size

5mg, 10mg

Published Research

5 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Kisspeptin-54 as a novel oocyte maturation trigger in in vitro fertilization

Abbara A, Jayasena CN, Christopoulos G, et al. (2015). Journal of Clinical Endocrinology and Metabolism. PubMed 26192876

Dose-finding study of kisspeptin-54 for oocyte maturation in women undergoing IVF treatment

Abbara A, Clarke SA, Islam R, et al. (2018). Journal of Clinical Investigation. PubMed 28854728

Kisspeptin administration stimulates gonadotropin release and is not altered by sex steroid feedback in healthy men

Dhillo WS, Chaudhri OB, Patterson M, et al. (2005). Journal of Clinical Endocrinology and Metabolism. PubMed 16174713

Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization

Jayasena CN, Abbara A, Comninos AN, et al. (2014). Journal of Clinical Investigation. PubMed 25036713

Kisspeptin modulates sexual and emotional brain processing in humans

Comninos AN, Wall MB, Demetriou L, et al. (2017). Journal of Clinical Investigation. PubMed 28112678

For laboratory research use only (in vitro). Not for human or animal use.

Research Use Certification

This website supplies laboratory reference materials intended solely for in vitro research purposes. By entering, you confirm: